We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 846

Intellectual Property Weekly Abstracts Bulletin Week of July 17, 2017
  • Borden Ladner Gervais LLP
  • Canada
  • July 19 2017

In this case, AbbVie brought an application against Samsung pursuant to the NOC Regulations. The parties agreed that a protective order was needed


Intellectual Property Weekly Abstracts Bulletin Week of July 3, 2017
  • Borden Ladner Gervais LLP
  • Canada
  • July 5 2017

Supreme Court of Canada invalidates the promise doctrine AstraZeneca Canada Inc. v. Apotex Inc., 2017 SCC 36 Drug: esomeprazole In this decision, the


ReMarks - IP Update2nd Quarter 2017
  • Marks & Clerk
  • Canada, China, European Union, Global, United Kingdom, USA
  • June 22 2017

The Unified Patent Court (UPC) Agreement requires ratification by at least 13 participating states in order to come into force, including France


Efficiency and planning - Federal Court issues Trial Management Practice Notice
  • DLA Piper LLP
  • Canada
  • May 18 2017

The Canadian Federal Court has provided new guidelines for efficient trial management of all trials over five days in length. These guidelines are


The Impact of CETA and Bill C-30 on Canada’s IP Landscape: Important Changes to Canadian Patent and Trademark Laws
  • Fasken Martineau DuMoulin LLP
  • Canada
  • December 5 2016

The Comprehensive Economic and Trade Agreement (CETA) was signed by Canada and the European Union (EU) on October 30, 2016. The next day, the Canadian


Changes to IP rights on the horizon: Canada introduces legislation to implement CETA
  • Gowling WLG
  • Canada
  • November 4 2016

We previously reported on important changes the recently signed Comprehensive Economic and Trade Agreement between Canada and the European Union


Portions of Apotex’s requested relief for being kept off the Viagra market struck
  • Gowling WLG
  • Canada
  • August 25 2016

In an Aug. 8, 2016 Ontario Superior Court of Justice decision Lederman J. ruled on a motion brought by the defendant Pfizer seeking to strike claims


International Council on Harmonisation Includes Generic Trade Organization (IGBA) for the First Time
  • McGuireWoods LLP
  • Canada, Global
  • June 16 2016

On June 15, 2016, the International Council for Harmonisation (ICH) (formerly the International Conference on Harmonisation)announced that the


Questionable Policy: New Canadian IP Enforcement Guidelines Miss the Mark on Pharma
  • Borden Ladner Gervais LLP
  • Canada
  • April 5 2016

On March 31, 2016, the Canadian Competition Bureau released a long-awaited substantive update of its Intellectual Property Enforcement Guidelines


Important Developments in Canadian Merger Control and IP Matters
  • Blake Cassels & Graydon LLP
  • Canada
  • April 4 2016

The Competition Bureau (Bureau) has obtained a significant remedy in a merger between non-Canadian companies that was not notifiable in Canada